Jubilant Pharmova informs about credit rating

27 Dec 2022 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jubilant Pharmova has informed that India Ratings and Research has assigned Long-term issuer rating of ‘IND AA+’ Rating for the company. The instrument-wise ratings are enclosed. The Company has received the rating letter from India Ratings and Research on December 26, 2022.

The above information is a part of company’s filings submitted to BSE.


Jubilant Pharmova Share Price

1130.85 -0.25 (-0.02%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.